Acquisitions - Additional Information (Detail) - Vetex Medical Limited [Member] - USD ($) $ in Millions		6 Months Ended
Jul. 02, 2021	Mar. 31, 2022
Business Acquisition [Line Items]
Cash paid	$ 39.9
Deferred consideration, contractual value	$ 3.5
Installment payment beginning period	2024
Installment payment ending period	2027
Contingent consideration, contractual value	$ 3.5
Contingency period ending year	2027
Developed Technology Rights [Member]
Business Acquisition [Line Items]
Acquired intangible assets amortized on straight-line basis, estimated useful life		12 years
Revolving Credit Facility [Member]
Business Acquisition [Line Items]
Business combination, consideration transferred, liabilities incurred	$ 10.0

Contingency, ending period, for business combination or asset acquisition.

No definition available.

Name:	srdx_AcquisitionContingencyPeriodEndingYear
Namespace Prefix:	srdx_
Data Type:	xbrli:gYearItemType
Balance Type:	na
Period Type:	duration

- Definition

Installment payment, beginning period, for business combination or asset acquisition.

+ References

No definition available.

+ Details

Name:	srdx_AcquisitionInstallmentPaymentBeginningPeriod
Namespace Prefix:	srdx_
Data Type:	xbrli:gYearItemType
Balance Type:	na
Period Type:	duration

- Definition

Installment payment, ending period, for business combination or asset acquisition.

+ References

No definition available.

+ Details

Name:	srdx_AcquisitionInstallmentPaymentEndingPeriod
Namespace Prefix:	srdx_
Data Type:	xbrli:gYearItemType
Balance Type:	na
Period Type:	duration

- Definition

Gross, contractual value of cash consideration to be transferred at a future date, if contingencies are met, by the acquirer to the former owners of the acquiree in a business combination.

+ References

No definition available.

+ Details

Name:	srdx_BusinessCombinationContingentConsiderationContractual
Namespace Prefix:	srdx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Gross, contractual value of cash consideration to be transferred at a future date by the acquirer to the former owners of the acquiree in a business combination.

+ References

No definition available.

+ Details

Name:	srdx_BusinessCombinationDeferredConsiderationContractual
Namespace Prefix:	srdx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Upfront payments to acquire businesses gross.

+ References

No definition available.

+ Details

Name:	srdx_UpfrontPaymentsToAcquireBusinessesGross
Namespace Prefix:	srdx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=srdx_VetexMedicalLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: